FI946156A - Targeted supply of growth factors that affect bone regeneration - Google Patents
Targeted supply of growth factors that affect bone regeneration Download PDFInfo
- Publication number
- FI946156A FI946156A FI946156A FI946156A FI946156A FI 946156 A FI946156 A FI 946156A FI 946156 A FI946156 A FI 946156A FI 946156 A FI946156 A FI 946156A FI 946156 A FI946156 A FI 946156A
- Authority
- FI
- Finland
- Prior art keywords
- growth factors
- bone regeneration
- affect bone
- targeted supply
- targeted
- Prior art date
Links
- 230000010478 bone regeneration Effects 0.000 title 1
- 239000003102 growth factor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
- C07F9/3817—Acids containing the structure (RX)2P(=X)-alk-N...P (X = O, S, Se)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90698092A | 1992-06-30 | 1992-06-30 | |
US08/026,800 US5505931A (en) | 1993-03-04 | 1993-03-04 | Acid cleavable compounds, their preparation and use as bifunctional acid-labile crosslinking agents |
PCT/US1993/006254 WO1994000145A1 (en) | 1992-06-30 | 1993-06-30 | Targeted delivery of growth factors for bone regeneration |
Publications (2)
Publication Number | Publication Date |
---|---|
FI946156A0 FI946156A0 (en) | 1994-12-29 |
FI946156A true FI946156A (en) | 1995-02-27 |
Family
ID=26701672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI946156A FI946156A (en) | 1992-06-30 | 1994-12-29 | Targeted supply of growth factors that affect bone regeneration |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0653941A1 (en) |
JP (1) | JPH07508979A (en) |
CN (1) | CN1092076A (en) |
AU (1) | AU4660093A (en) |
CA (1) | CA2139323A1 (en) |
FI (1) | FI946156A (en) |
HU (1) | HUT71220A (en) |
IL (1) | IL106159A0 (en) |
MX (1) | MX9303963A (en) |
WO (1) | WO1994000145A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5462725A (en) * | 1993-05-06 | 1995-10-31 | The Dow Chemical Company | 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents |
US5776193A (en) | 1995-10-16 | 1998-07-07 | Orquest, Inc. | Bone grafting matrix |
US6902584B2 (en) | 1995-10-16 | 2005-06-07 | Depuy Spine, Inc. | Bone grafting matrix |
GB9702978D0 (en) * | 1997-02-13 | 1997-04-02 | Ciba Geigy | Compounds |
US6794371B1 (en) * | 1999-10-18 | 2004-09-21 | The Dow Chemical Company | Aminoalkylenephosphonates for treatment of bone disorders |
AU1092601A (en) * | 1999-10-18 | 2001-04-30 | Dow Global Technologies Inc. | Aminoalkylenephosphonates for treatment of bone disorders |
US6565828B2 (en) * | 2000-04-07 | 2003-05-20 | Bristol-Myers Squibb Company | Macrocyclic chelants for metallopharmaceuticals |
WO2004089356A2 (en) * | 2003-04-03 | 2004-10-21 | Semafore Pharmaceuticals Inc. | Targeted bone marrow protection agents |
EP1932850A1 (en) * | 2006-12-11 | 2008-06-18 | Thermphos Trading GmbH | Phosphonate compounds |
EP3206670A4 (en) | 2014-10-14 | 2018-06-20 | Samuel Lynch | Compositions for treating wounds |
WO2016123454A1 (en) | 2015-01-29 | 2016-08-04 | Board Of Trustees Of Miching State University | Cryptic polypeptides and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5011913A (en) * | 1985-06-28 | 1991-04-30 | The Procter & Gamble Company | Diphosphonate-derivatized macromolecules |
JPH02268190A (en) * | 1989-04-07 | 1990-11-01 | Fujisawa Pharmaceut Co Ltd | Conjugate from medical compound and diphosphonic acid derivative |
US5208219A (en) * | 1991-02-14 | 1993-05-04 | Celtrix Pharmaceuticals Inc. | Method for inducing bone growth |
WO1992020371A1 (en) * | 1991-05-10 | 1992-11-26 | Celtrix Pharmaceuticals, Inc. | Targeted delivery of bone growth factors |
-
1993
- 1993-06-28 IL IL106159A patent/IL106159A0/en unknown
- 1993-06-30 AU AU46600/93A patent/AU4660093A/en not_active Abandoned
- 1993-06-30 WO PCT/US1993/006254 patent/WO1994000145A1/en not_active Application Discontinuation
- 1993-06-30 CN CN93109549A patent/CN1092076A/en active Pending
- 1993-06-30 JP JP6502666A patent/JPH07508979A/en active Pending
- 1993-06-30 CA CA002139323A patent/CA2139323A1/en not_active Abandoned
- 1993-06-30 MX MX9303963A patent/MX9303963A/en unknown
- 1993-06-30 EP EP93916894A patent/EP0653941A1/en not_active Withdrawn
- 1993-06-30 HU HU9403840A patent/HUT71220A/en unknown
-
1994
- 1994-12-29 FI FI946156A patent/FI946156A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JPH07508979A (en) | 1995-10-05 |
IL106159A0 (en) | 1993-10-20 |
WO1994000145A1 (en) | 1994-01-06 |
CA2139323A1 (en) | 1994-01-06 |
EP0653941A1 (en) | 1995-05-24 |
AU4660093A (en) | 1994-01-24 |
CN1092076A (en) | 1994-09-14 |
HUT71220A (en) | 1995-11-28 |
HU9403840D0 (en) | 1995-02-28 |
FI946156A0 (en) | 1994-12-29 |
MX9303963A (en) | 1995-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE235481T1 (en) | SUBSTITUTED BENZOPYRANE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION | |
FI932426A (en) | GLANSPIGMENT BASERADE PAO FLERFALDIGT BELAGDA SKIVARTADE METALLISKA SUBSTRAT | |
DE69325089D1 (en) | SURGICAL ENDOCLIP | |
DE69316885D1 (en) | BONE FASTENING ARRANGEMENT | |
FI946156A0 (en) | Targeted supply of growth factors that affect bone regeneration | |
FI953709A (en) | Procedure for promoting hair growth | |
FI951380A (en) | Controlled formation of olefin oligomers | |
BR9307470A (en) | Implant | |
NO940651D0 (en) | Osteosynthesis aid for bone attachment | |
NO933216D0 (en) | implant | |
FI931969A (en) | CONTROLLING AV PERFUSIONSHASTIGHETER I KONTINUERLIG BIOREAKTORODLINGAV DJURCELLER | |
ATE235494T1 (en) | IMINO-AZA ANTHRACYCLONE DERIVATIVES FOR THE TREATMENT OF AMYLOIDOSIS | |
NO970842D0 (en) | Promoting the growth of chickens | |
NO945093D0 (en) | Targeted release of growth factors for bone regeneration | |
FI934146A0 (en) | FILTER ANORDER FOR SEQUENCE SUPPLY SEGMENTIZER | |
DE69819503D1 (en) | USE OF 7-APHA-METHYL-17-ALPHA-ETHYNYL-ESTRANE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSE | |
KR930020989U (en) | Tissue hanger for easy replacement of tissue | |
NO940131D0 (en) | Salts of 4-pyrimidinone derivatives for framasoytic use | |
UA25791A (en) | METHOD OF CONTROLLING THE EFFECTIVENESS OF TREATMENT OF STABLE STECHOCARDIA | |
DE69510104D1 (en) | Block-shaped growth medium | |
BR7200299U (en) | APPLIANCE FOR CONTROLLED HEMODIALISE | |
ITUD920181A1 (en) | ARTIFICIAL CIGARETTE | |
IT228017Y1 (en) | ANCHORAGE FOR DENTAL PROSTHESES | |
KR940007095U (en) | Toothbrush sterilizer | |
KR940007195U (en) | Toothbrush sterilizer |